BU-NOT-SET

CONTACT US
Identifying impurities using advanced analytics
  • Analytical chemistry
Eyes
Insight
Recipharm on the impact of COVID-19 on API supply
  • Industry trends
Eyes
Insight
The role of excipient selection in the development of orally disintegrating tablets
  • Drug product
Eyes
Insight
Solving analytical method challenges to advance animal antibiotic
  • Analytical chemistry
Hand vial stand
Case study
The outlook for a year of change
  • Industry trends
Eyes
Insight
Can oral solid dose keep its place as the leading dosage form?
  • Drug product
Eyes
Insight
Relocating API supply to avoid over-reliance
  • Drug substance
Eyes
Insight
Modified release fixed dose combination product with two poorly soluble drug substances
  • Drug product
pellets
Case study
Patient centricity during drug development and commercialisation
  • Drug product
Eyes
Insight
Insight
  • Drug product
  • Manufacturing
How pre-filled syringes are changing drug delivery of biologics
Webinar
  • Drug product
Choosing the right sterile container for your drug product
Video
  • Manufacturing
ReciBioPharm is advancing the future of xRNA manufacturing
Webinar
  • Biologics
  • Manufacturing
Faster, smaller, smarter: Intelligent manufacturing of mRNA through the power of process analytical technologies
Insight
  • Biologics
ReciBioPharm: The Economic Case for Continuous Manufacturing
Insight
  • Drug product
  • Manufacturing
The innovation bottleneck: Why drug development is so tough, and how connectivity and predictive analysis can overcome obstacles
Insight
  • Industry trends
What are the key trends shaping drug development in 2025?
Insight
  • Biologics
ReciBioPharm Is Advancing xRNA Production
eBook
  • Drug product
  • Manufacturing
Navigating the complexities of pre-filled syringes for biologics